GAO Slams FDA Inspection Process

Law360, New York (April 22, 2008, 12:00 AM EDT) -- Despite a recent attempt to step up its vigilance, the U.S. Food and Drug Administration is still not doing all it could be to prevent contaminated drugs from entering the U.S., according to a new study done by the U.S. Government Accountability Office.

The study's results, which were made public on Tuesday, reveal that although the FDA has taken steps to improve its foreign drug inspection process, the agency still has not addressed the problems with the system exposed in earlier GAO testimony.

“Recent FDA initiatives...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.